Page URL:

Genetic markers poor at heart disease prediction

8 March 2010
Appeared in BioNews 548

A genetic risk score based on several genetic markers associated with cardiovascular disease (CVD) does not improve the prediction of CVD risk, research published in the Journal of the American Medical Association has suggested. In contrast, the authors found that family history of CVD was a strong predictor of CVD risk.

Nina Paynter and colleagues, from the Brigham and Women's Hospital in Boston, searched the National Human Genome Research Institute catalogue of genome-wide association studies published between 2005 and 2009 to identify genetic markers associated with CVD, and developed two genetic risk scores. The primary genetic risk score included 101 SNPs (single nucleotide polymorphisms) associated with CVD and its intermediate conditions, such as high blood pressure or cholesterol levels. The secondary genetic risk score included 12 SNPs directly associated with incidents of CVD. The authors then tested whether these genetic risk scores were able to predict CVD events, based on data from 19,313 participants in the Women's Genome Health Study, who were followed up during a median period of 12.3 years. Genetic, health and family history information were collected from all participants.

During the follow-up, 777 CVD events occurred in this group of women (199 heart attacks, 203 strokes, 63 cardiovascular deaths, 312 coronary artery revascularisations). When used alone, the genetic risk score was not able to predict CVD risk. After adjustment for age, the genetic risk score was associated with an increased risk of CVD. However, after adjusting for all traditional risk factors (blood pressure, smoking status, diabetes, cholesterol, C-reactive protein, and family history of heart attacks), the genetic risk score was not able to predict CVD risk. The authors concluded that the genetic risk score was not associated with a significant improvement in CVD risk prediction beyond the traditional risk factors.

Many researchers hope that genome-wide association studies - which have identified several genetic markers associated with several common complex diseases including CVD - could be used to improve the prediction of disease risk. This study suggests that in the case of CVD, however, a genetic risk score based on genome-wide association studies does not enhance the accuracy of established prediction methods that do not rely on genetic information.

The authors stressed that their findings do not undermine the importance of genetic studies in understanding disease, but show they are not clinically useful for predicting CVD risk. They wrote: 'While the importance of genetic data in understanding biology and etiology is unchallenged, we did not find evidence in this study of more than 19,000 women to incorporate the current body of known genetic markers into formal clinical tools for cardiovascular risk assessment'.

They suggest that family history may be the strongest predictor of CVD because it 'integrates shared genetics, shared behaviours, and environmental factors'.

The authors also state that 'genome-wide testing is increasingly available and marketed to the general public', and their findings call into question the utility of these tests. 'Our study finds no clinical utility in a multilocus panel of SNPs for cardiovascular risk based on the best available literature'.

Association between a literature-based genetic risk score and cardiovascular events in women
JAMA |  17 February 2010
Genetic factors and cardiovascular risk prediction in women
Phg Foundation |  2 March 2010
Use of Multiple Genetic Markers Not Linked With Better Risk Prediction of CVD
Newswise |  16 February 2010
13 February 2012 - by Luciana Strait 
A genetic variant has been linked to an increased risk of a common type of stroke. Researchers identified an alteration in a gene called HDAC9 that is more common in people who have had an ischaemic stroke than in those who have not. The study also replicated variants previously associated with subtypes of ischaemic strokes...
4 July 2011 - by Dr Marianne Kennedy 
Scientists have linked a so-called ‘lean gene’ to an increased likelihood of developing heart disease and type II diabetes....
27 June 2011 - by Antony Starza-Allen 
A genetic mutation has been associated with a rare and potentially serious heart condition called peripartum cardiomyopathy (PPCM) that can affect woman before, during or shortly after childbirth. Researchers say the findings could lead to the development of diagnostic tests for PPCM....
31 May 2011 - by Dr Jay Stone 
A US company has launched a mail order genetic test that claims to provide 'athletes and parents of young sports competitors' with information about the user's athletic strengths, what type of training will be most beneficial, and potential injury risks...
14 March 2011 - by MacKenna Roberts 
An international research consortium has discovered 13 new genetic markers and confirmed ten previously identified markers associated with heart disease. The study, one of the world's largest, more than doubles the known genetic risk factors for coronary artery disease, a common cause of heart attacks and strokes....
7 December 2009 - by Antony Starza-Allen 
As our understanding of genetics and associated disorders has developed, many genetic tests performing functions - from predicting certain genetic predispositions and identifying rare monogenetic disorders, to ancestry and other 'novelty' tests - have been introduced to the healthcare market. Many geneticists are concerned about the regulation of these tests, which are performed by the NHS, the private sector, or distributed directly to consumers. Experts are calling for more transparent eval...
12 October 2009 - by Dr Jess Buxton 
Companies offering 'direct-to-consumer' genetic tests to predict the risk of common conditions such as heart attack and rheumatoid arthritis should provide more information to consumers about the limitations of their services, say US scientists. Their recommendations follow the finding that several tests from two such companies gave different results for the same five individuals. Genome pioneer Craig Venter and colleagues also call for more research into the predictive power of geneti
20 April 2009 - by Adam Fletcher 
One of the most innovative developments to arise from the completion of the Human Genome Project in 2003, and the International HapMap Project in 2005 has been the exploration of how and why changes in DNA can predispose individuals to disease. A popular method for identifying causative...
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.